Since its inception in 1991, Marco Pharma International (MPI) has become a beacon of excellence in natural medicine, offering a diverse portfolio of homeopathic medicines, herbal extracts, and nutrient supplements. By harmonizing the time-honored traditions of German Biological Medicine with contemporary healthcare methodologies, MPI has made natural, plant-based remedies an integral part of medical practices across the United States. The...
Anavex Life Sciences is at the forefront of innovative research in the
quest to combat neurodegenerative diseases. This biopharmaceutical company,
often referred to simply as Anavex, is dedicated to developing therapies that
address the unmet medical needs of patients suffering from Alzheimer's,
Parkinson's, and other central nervous system disorders.
Founded on cutting-edge science, Anavex employs a unique approach
to drug discovery. The...
Anavex Life Sciences has announced significant findings from its phase 2b/3 trial of blarcamesine, an
investigational treatment for early Alzheimer’s disease. The trial results
indicate that blarcamesine could play a crucial role in reducing amyloid-ß
biomarkers and slowing neurodegeneration.
Conducted across multiple centers, this double-blind, placebo-controlled study enrolled 508
participants. Patients were randomized to receive...